Dima Biotechnology logo

Dima Biotechnology

Recombinant monoclonal antibodies and membrane proteins for drug discovery.

6 employees · est. 2018 · Rockville, United States

VS
Harbour BioMed logo

Harbour BioMed

Healthy Life · Breakthrough Medicines

113 employees · est. 2016 · Cambridge, United States

Harbour BioMed is the older company (2018 vs 2016); Harbour BioMed is the larger of the two.

Side-by-Side Comparison

Dima Biotechnology Harbour BioMed
Founded
2018 2016 older
Headquarters
Rockville, United States Cambridge, United States
Employees
6 113 larger
Industry
Biotechnology, Health Care Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Angel IPO
Total Funding
Not tracked yet $533.80M
Funding Rounds
1 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech, Monoclonal Antibodies, Membrane Proteins, Drug Discovery, Preclinical R&D, Biopharma Research, Antibody Technology, Mammalian Cell Expression, GPCRs, Ion Channels, B Cell Antibody Discovery, Antibody Engineering, Screening Processes, Therapy Development, Innovation Biopharmaceutical, Antibody Therapeutics, Oncology, Immunology, Novel Antibody Discovery, Harbour Mice® Platform, Monoclonal Antibodies, Heavy Chain Only Antibodies, Immune Cell Engagers, HBICE® Technology, Transgenic Mouse Platforms, B-cell Cloning, Immuno-oncology, Inflammatory Diseases, Drug Discovery And Development
Website
dimabio.com harbourbiomed.com
Dima Biotechnology logo

About Dima Biotechnology

Dima Biotechnology, established in 2019, is a US-based biotech company focusing on preclinical R&D solutions for the Biopharma industry. The company specializes in the development of recombinant monoclonal antibodies and membrane proteins for drug discovery. Its \nslogan: Recombinant monoclonal anti...

Harbour BioMed logo

About Harbour BioMed

Harbour BioMed, operating under the slogan "Healthy Life · Breakthrough Medicines," is a dynamic player in the global biopharmaceutical landscape. Established in 2016, the company has rapidly developed a strong foundation in oncology and immunology through innovative antibody therapeutics. This Uni...

We will tell you when either one moves

BounceWatch watches Dima Biotechnology and Harbour BioMed for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dima Biotechnology and Harbour BioMed — by email.

Frequently Asked Questions

Dima Biotechnology — Recombinant monoclonal antibodies and membrane proteins for drug discovery. . Harbour BioMed — Healthy Life · Breakthrough Medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dima Biotechnology has raised undisclosed funding while Harbour BioMed has raised $533.80M.
Dima Biotechnology and Harbour BioMed operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dima Biotechnology with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Dima Biotechnology on 12 Sep 2024, and Harbour BioMed on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes